Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
84.96
-0.22 (-0.26%)
Mar 23, 2026, 4:00 PM EDT - Market closed

Guardant Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-416.28-436.37-479.45-654.59-384.77
Depreciation & Amortization
39.7442.3942.8835.9622.27
Stock-Based Compensation
166.22140.4190.7694.69151.45
Other Adjustments
39.9974.58-33.01152.9142.5
Change in Receivables
-28.18-21.398.380.38-44.35
Changes in Inventories
-14.79-9.14-10.35-20.93-7.96
Changes in Accounts Payable
52.75-2.825.1960.3334.8
Changes in Accrued Expenses
--83.4--
Changes in Unearned Revenue
19.4618.661.739.872.78
Changes in Other Operating Activities
-43.67-46.18-34.5111.91-25.73
Operating Cash Flow
-184.76-239.86-324.98-309.46-209.02
Capital Expenditures
-48.31-35.09-20.49-77.46-75.04
Purchases of Investments
-827.23-314.82-635.5-327.72-940.23
Proceeds from Sale of Investments
307.3288.61,496555952.11
Payments for Business Acquisitions
-58.99----
Investing Cash Flow
-627.2-261.31840.25149.82-63.16
Long-Term Debt Issued
402.5----
Net Long-Term Debt Issued (Repaid)
402.5----
Issuance of Common Stock
360.1414.84482.5411.9417.87
Repurchase of Common Stock
-75.55-15.68-11.2-7.88-83.76
Net Common Stock Issued (Repurchased)
284.6-0.84471.354.06-65.89
Other Financing Activities
-15.96-0.156.03-193.16-0.93
Financing Cash Flow
671.13-1477.38-189.09-66.82
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.49-1.77-0.91-1.6-1.69
Net Cash Flow
-140.34-503.93991.74-350.34-340.69
Free Cash Flow
-233.07-274.94-345.46-386.92-284.05
FCF Margin
-23.73%-37.20%-61.26%-86.07%-76.02%
Free Cash Flow Per Share
-1.86-2.24-3.08-3.79-2.80
Levered Free Cash Flow
-8.6-468.54-411.59-634.9-454.55
Unlevered Free Cash Flow
-430.75-477.07-497.68-525.64-460.2
Updated Feb 19, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q